Analyses | Model | DIC | pD | Deviance | Between study | prop3 | prop4 |
---|---|---|---|---|---|---|---|
AgD NMA – Unadjusted | Fixed | 111.78 | 40.95 | 70.83 | 0.114 (0.005, 0.325) | 6/96 | 6/96 |
One-stage IPD-AgD NMA – CD4 + HIV RNA + Male | Fixed | 102.45 | 43.99 | 58.46 | 0.077 (0.003, 0.254) | 4/96 | 3/96 |
One-stage IPD-AgD NMA – CD4 + Male | Fixed | 101.17 | 42.98 | 58.19 | 0.085 (0.006, 0.263) | 4/96 | 3/96 |
One-stage IPD-AgD NMA – CD4 + HIV RNA | Fixed | 103.91 | 43.03 | 60.88 | 0.094 (0.005, 0.297) | 5/96 | 3/96 |
One-stage IPD-AgD NMA – HIV RNA + Male | Fixed | 100.66 | 42.97 | 57.69 | 0.072 (0.003, 0.238) | 4/96 | 3/96 |
One-stage IPD-AgD NMA – CD4 | Fixed | 103.22 | 41.91 | 61.31 | 0.101 (0.007, 0.296) | 4/96 | 3/96 |
One-stage IPD-AgD NMA – HIV RNA | Fixed | 99.43 | 42.04 | 57.39 | 0.074 (0.004, 0.241) | 4/96 | 3/96 |
One-stage IPD-AgD NMA – Male | Fixed | 101.22 | 42.02 | 59.2 | 0.088 (0.006, 0.275) | 4/96 | 3/96 |